The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will discuss Respiratory Syncytial Virus (RSV):...
News & Insights
The M&D Buzz
Get a glimpse of the news, events, accolades, and insights that Morris & Dickson brings to the pharmaceutical industry
M&D Clinical Corner: Community Pharmacist’s Guide to Immunization
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will discuss Immunization: COVID-19 Vaccines...
M&D Clinical Corner: Community Pharmacist’s Guide to Continuous Glucose Monitoring
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will discuss continuous glucose monitoring (CGM):...
M&D Clinical Corner: Community Pharmacist’s Guide to Social Determinants of Health
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will discuss social determinants of health (SDoH)....
M&D Clinical Corner: Community Pharmacist’s Guide to Stroke Awareness
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will provide an overview of strokes including:...
Morris & Dickson Statement on the Fifth Circuit Decision Staying the DEA’s Order Indefinitely, Pending Appeal
Jun 16, 2023 | News
Morris & Dickson is grateful to the Fifth Circuit Court of Appeals for promptly granting its request to stay the Drug Enforcement Administration’s recent license revocation against the company. The Fifth Circuit’s decision means that it...
Update on DEA revocation order against Morris & Dickson
Jun 2, 2023 | News
Today, Morris & Dickson filed an appeal on the DEA’s attempt to revoke our registration to the U.S. Court of Appeals for the Fifth Circuit. The company has also asked the Court to stay DEA’s Order to prevent it from taking effect for an...
Update on Morris & Dickson’s Ongoing Discussion with DEA: Business continues as usual; DEA license remains active
May 26, 2023 | News
Morris & Dickson is grateful to the DEA Administrator for delaying the effective date of the Order to allow time to settle these old issues, which has been our goal since this started years ago. In the ensuing time, the company has voluntarily invested millions to...
Morris & Dickson statement in response to a news story published this morning that says the DEA may attempt to revoke the company’s registration
May 24, 2023 | News
Morris & Dickson takes seriously its commitment to ensure strict compliance with all DEA regulations. We strongly believe any attempt to revoke our registration would be unwarranted and unjustified. Most importantly, any decision the DEA makes will not disrupt our...
M&D Clinical Corner: Community Pharmacist’s Guide to Pharmacy-administered Injectables.
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will provide an overview of Pharmacy-Administered...
Milken Institute Highlights M&D in Recent Supply Chain Report
Morris & Dickson, the nation’s largest, independently owned, full-line pharmaceutical distributor based in Shreveport, Louisiana, was recently highlighted in a publication by the Milken Institute Center for Public Health. The report, “Envisioning...
M&D Clinical Corner: Overview of Biosimilar Drugs
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will provide an overview of biosimilar drugs...








